ABSTRACT
We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection.
Subject(s)
COVID-19 , Glomerulonephritis , Nephritis , Antibodies, Antineutrophil Cytoplasmic , COVID-19/complications , Glomerulonephritis/drug therapy , Glomerulonephritis/therapy , Humans , Male , SARS-CoV-2ABSTRACT
Presentamos el caso de un varón afecto por neumonía SARS-CoV-2 grave, que a la vez comienza con una glomerulonefritis rápidamente progresiva p-ANCA positiva. Se comentan las distintas posibilidades terapéuticas haciendo hincapié en la idoneidad de su administración según el momento evolutivo de la infección. (AU)
We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection. (AU)
Subject(s)
Humans , Male , Nephrology , Coronavirus Infections/epidemiology , Anti-Glomerular Basement Membrane Disease/therapy , Pneumonia/therapy , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/therapy , AortitisABSTRACT
We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection.
